Angion Enrolls First Patients in Phase 2 Clinical Trial of ANG-3777 in Patients with Acute Lung Injury Associated with COVID-19 Pneumonia

San Francisco, CA and Covington, KY, August 4, 2020 — Angion Biomedica Corp. (Angion), a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials